MBX Biosciences (MBX) Prepaid Assets (2023 - 2026)

MBX Biosciences has reported Prepaid Assets for 4 years, with the latest figure at $8.6 million in Q1 2026.

• Quarterly Prepaid Assets rose 1267.25% year-over-year to $8.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.6 million (up 1267.25% YoY) and the FY2025 annual result came in at $7.8 million, up 52.5% from the prior year.
• Prepaid Assets rose to $8.6 million in Q1 2026 per MBX's latest filing, from $7.8 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $8.6 million in Q1 2026 and troughed at $133000.0 in Q4 2023.
• A 4-year average of $3.5 million and a median of $2.6 million in 2025 frame the typical range for Prepaid Assets.
• The sharpest annual moves came in 2024 and 2025: Prepaid Assets surged 3762.41% in 2024, then grew 5.25% in 2025.
• Over 4 years, Prepaid Assets stood at $133000.0 in 2023, then soared by 3762.41% to $5.1 million in 2024, then surged by 52.5% to $7.8 million in 2025, then climbed by 9.25% to $8.6 million in 2026.
• According to Business Quant data, Prepaid Assets over the past three periods registered $8.6 million, $7.8 million, and $882000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.